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We have studied the cytotoxic activity of rat basophilic leukemia (RBL) cells transfected with 
cDNAs for the cytotoxic T lymphocyte (CTL) granule components, cytolysin (perforin), gran- 
zyme A, and granzyme B. With red cell targets, cytolysin expression conferred potent hemolytic 
activity,  which was not influenced by coexpression  of granzymes. With tumor targets,  RBL 
cells expressing cytolysin alone were weakly cytotoxic, but both cytolytic and nucleolytic activity 
were enhanced by coexpression of granzyme B. RBL cells expressing all three CTL granule com- 
ponents showed still higher cytotoxic activities,  with apoptotic target death. Analysis of the 
cytotoxic activity of individual transfectant clones showed that cytolytic and nucleolytic activity 
correlated with granzyme expression but was independent of cytolysin expression  within the 
range examined. A synergism between granzymes A and B was apparent when the triple trans- 
fectant was compared with RBL cells expressing cytolysin and one granzyme. These data impli- 
cate granzymes as the major mediators of tumor target damage by cytotoxic lymphocytes. 
T 
he  granule  exocytosis  model  for  lymphocyte  cyto- 
toxicity postulates that target cell recognition triggers 
a secretory process in which preformed cytoplasmic granules 
fuse with the effector cell plasma membrane in the vicinity 
of the bound target cell, releasing cytotoxic molecules into 
a junctional region created by cell-cell adhesion (1). The ini- 
tial  cytotoxic mediator identified in cytotoxic lymphocyte 
granules was cytolysin or perforin, a 70-kD protein that un- 
dergoes a calcium-dependent conformational change and in- 
serts into membranes, forming large functional pores with 
corresponding structures visible by negative stain electron mi- 
croscopy (2). There is considerable evidence that this pathway 
is the major effector mechanism for cytotoxic lymphocytes, 
including the major defects in antiviral  and allogeneic CTL 
and NK activity in mice whose perforin/cytolysin gene was 
rendered nonfunctional (3). 
The granule exocytosis pathway with cytolysin as the sole 
lethal mediator is deficient in two significant respects. First, 
membrane damage does not account for the observed average 
delay of 1-2 h required for target death after delivery of the 
lethal hit (4). Second, it does not account for the apoptotic 
morphology of most dying target cells and the DNA break- 
down ("nucleolytic activity"), which typically accompanies 
apoptotic morphology (5). We have sought other granule- 
delivered mediators that could cause secondary lethal damage 
after entry into target cells whose membranes were permea- 
bilized (6), focusing on the serine proteases termed granzymes. 
Although seven granzymes are expressed by cloned murine 
CTL lines maintained in IL-2 (7), only granzymes A and B 
are expressed by the potent in vivo PEL CTL (8). These two 
enzymes have markedly different enzymatic specificities, with 
granzyme A being a "tryptase" that is, cleaving at Arg and 
Lys residues, while granzyme B prefers Asp at its cleavage 
site. Granules from NK cells and human CTL also express 
multiple granzymes, including two with nominally similar 
specificities to granzymes A  and B (9,  10). 
Several lines of evidence argue that granzymes mediate target 
cell damage during lymphocyte-mediated  cytotoxicity.  Both 
granzyme A- and B-like proteases have the ability to trigger 
apoptotic nuclear  damage and cell death when introduced 
into cells by detergents or cytolysin (11). More directly, mice 
whose granzyme B gene was inactivated produced CTL with 
defective cytolytic and nucleolytic activity (12). Another ap- 
proach to testing the functional role of granzymes in cyto- 
toxicity  has  been  their  controlled expression  along with 
cytolysin in  the rat  basophilic leukemia (RBL) 1 cell line, 
which has a well-defined regulated secretory pathway con- 
trolled by the IgE Fc receptor.  When transfected  with the 
cDNA for cytolysin, RBL expressed the protein in secretory 
granules,  and  these  RBL-cy  acquired  a  potent  IgE-anti- 
1Abbreviations used in this paper: BAAD-pNA, Boc-Ala-Ala-Asp-pNA;  BLT, 
Cbz-Lys-SBz; RBL, rat basophilic leukemia. 
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cells (13).  However, these cells had only a modest cytolytic 
ability on tumor targets, without accompanying apoptotic 
nuclear damage (14).  When granzyme A was coexpresssed 
along with cytolysin in RBL, these double transfectants killed 
tumor cells considerably more efficiently with apoptotic nu- 
clear damage, but there was no additional lytic potency against 
red cell targets  (15). 
The above-mentioned studies provide strong evidence that 
granzymes can trigger an "internal disintegration" pathway 
of target death after their entry into the cell. In our experi- 
ments, we have tested the abilities of both granzymes A and 
B to contribute to cytotoxic activity on tumor targets when 
expressed in RBL cells  along with cytolysin. We find that 
expression of granzyme B along with cytolysin enhances cyto- 
toxic activity compared to RBL cells expressing cytolysin only 
(as was found for granzyme A),  and RBL cells expressing 
both granzymes as well as cytolysin display a potent cyto- 
toxic activity comparable with cloned CTL. Granzymes A 
and B appear to interact synergistically to provide enhanced 
cytolytic and nucleolytic activity. Analysis of individual trans- 
fectant clones shows that granzyme expression controls their 
cytotoxic activity. 
Materials  and  Methods 
Cells and Chemicals.  RBb2H3 cells (a gift of Dr. Reuben Siriga- 
nian, National Institutes of Health [NIH], Bethesda,  MD) were 
maintained in DME containing 15% FCS, 4 mM L-glutamine, and 
100/~g/ml each of penicillin and streptomycin, as described previ- 
ously (13). Cloned murine CTL line TIM448, specific for H-2K  b 
(provided by Terri Munitz and Alfred Singer, NIH) was used as 
a positive control for cytotoxic activity and granule protein ex- 
pression. Affinity-purified anti-DNP IgE (16) was a gift from Juan 
Rivera (NIH), and covalently cross-linked heteroconjugate anti- 
body 2C11xce-DNP (17) was kindly provided by Dr. David Segal 
(NIH). The granzyme B substrate Boc-Ala-Ala-Asp-pNA was pur- 
chased from Bachem (King of Prussia,  PA). 
RBL Transfection  and Selection.  For tLBL transfection with gran- 
zyme B cDNA, a granzyme B expression vector was constructed 
by use of the mouse granzyme B (CTLA1) cDNA in PUC9 (a 
gift from Dr. Pierre Golstein,  Centre d'Immunologie Marseille- 
Luminy, Marseille, France). The granzyme B cDNA was excised 
with BamHI and SmaI digestions and recloned into the pSVL ex- 
pression  vector (Pharmacia  Inc.,  Piscataway, NJ)  via blunt and 
BamHI ligations. Cytolysin and granzyme A cDNAs were cloned 
into the pCDL/SRcr expression vector as described (15). Transfec- 
tion was by electroporation (500 mV, 260/~F) by use ofa genepulser 
(Bio-Rad Laboratories,  Richmond, CA) as described (14). For a 
single gene transfection  with 107 RBL ceils, 30 #g of expression 
vector was mixed with 1 #g of pSV3-neo, while double transfec- 
tants with cytolysin and one granzyme were made with 15/zg of 
each expression vector and I/zg pSV3-neo. Selection with geneticin 
(GIBCO BILL, Gaithersburg,  MD) was begun 2 d after transfec- 
tion, and the antibiotic resistant clones that grew out were tested 
for expression. For these screening purposes, cytolysin expression 
was assayed by cytotoxicity with red cell targets, granzyme A ex- 
pression by Cbz-Lys-SBz (BLT)-esterase assay, and granzyme B by 
reverse transcription PCR (18) (sense primer, 5'GATCCTCCTGCT- 
ACTGCTGACCTTG3', and antisense primer,  5'GGCCTTACT- 
CTTCAGCTTTAGCAGC3'). 
RBL-cy-gza-gzb were produced by secondary transfection of the 
RBL-cy-gzb clone 501 as described above, with 1/zg of the selec- 
tion vector pSV2/bsr (Funakoshi,  Tokyo, Japan)  (19). This pro- 
vides resistance to the antibiotic blasticidin S (ICN, Aurora, Ohio), 
which was used at 10/zg/ml for selection after 3 d. 
Expression of Transfected  Granule Components.  Granzyme A pro- 
tein expression was assessed using the BLT-esterase assay (20) on 
cell extracts in 0.1% Triton X-100. Similarly, granzyme B protein 
expression was measured  on an extract of 2  x  106 cells by fol- 
lowing hydrolysis of Boc-Ala-Ala-Asp-pNA (21) after a 24-h incu- 
bation. 
Granule protein mRNA expression was monitored by Northern 
blot analysis of the transfectant clones. Total RNA was extracted 
via the guanidinium thiocyanate-phenol-chloroform procedure (22). 
For Northern blot analysis, 20/~g of total cellular RNA from each 
sample was electrophoresed  on a 1% formaldehyde gel and trans- 
ferred to a membrane (Nytran; Schleicher & Schuell, Keene, NH). 
Full length mouse cDNAs of cytolysin, granzyme A, granzyme 
B, and fl-actin (Clonetech, Palo Alto, CA) were cut out from each 
expression vector and labded with ce-[32P]dCTP (Dupont, Boston, 
MA) by use of a random hexamer oligonucleotide priming kit (Phar- 
macia Inc.). Labeled probe was hybridized with the filters at 42~ 
in formamide-containing hybridization solution and washed with 
2x  SSC, 0.1% SDS, at 60~  before analysis. After analysis, bound 
probe was removed by washing with 5 mM Tris, pH 8.0, 0.2 mM 
EDTA, 0.05% pyrophosphate,  0.1x  Denhart's for 2 h at 64~ 
and the blots were reexposed to other probes. For quantitation, 
the membrane was exposed to phosphor screens, and specific ra- 
dioactivity was quantitated by phosphorimager (Molecular  Dy- 
namics, Sunnyvale, CA). Granule component mRNA levels were 
normalized  to those of the housekeeping  gene ~-actin. 
To allow for easy comparison, expression of each of the granule 
proteins and mRNAs in the murine CTL line was measured, and 
the values in the RBL transfectants were reported as a percentage 
of this CTL level. 
Cytotoxicity Experiments.  For target cells, we used fresh human 
RBC, mouse thymoma line EL4, mouse mastocytoma line P815, 
human acute T cell leukemia line Jurkat, and mouse fibroblast line 
L929. Target cell labeling by SlCr and 12sI-UDR for DNA release 
assays were performed as described in detail previously (13). In all 
cases, target cells were TNP modified by use of trinitrobenzene 
sulfonate, CTL recognition was via the antihapten  x  anti-CD3 
heteroconjugate,  and RBL recognition was via IgE anti-DNP, as 
previously described (13). Experiments were carried out in 200/zl 
vol in 96-well round-bottom microtiter plates with 104 target cells 
and varying numbers of effector cells per well. After 4 h of incuba- 
tion, 100 td of supernatant was harvested from each well, followed 
by addition of 100/zl of 0.2% Triton X-100 in PBS. After mixing 
and centrifugation, a second 100/xl of supernatant was harvested 
from each well. Triplicate data points were used and the released 
125I-DNA combined from each harvest for each well. Each marker 
release was calculated by the following formula, which includes 
a correction  for spontaneous  release from target cells alone: Cor- 
rected percent marker release =  (cpms~mple  --  cpmspo  .......  )/(cpm~ot~l 
-  cpmsvo,~n~ous). 
Data relating cytotoxicity and granule component expression 
were entered into CricketGraph (Computer Associates, San Diego, 
CA) and analyzed by its linear regression  analysis program. 
Microscopic  Analysis for Apoptotic Nuclei in Target Cells.  To iden- 
tify apoptotic nuclear morphology in target cells incubated with 
RBL transfectants, 1-2  x  106 target cells were prelabeled with the 
lipid probe DiIC16 (Molecular Probes, Inc., Eugene,  OR) by in- 
cubation with a 10/zM solution for 20 rain at 37~  followed by 
1038  Granzymes  A and B as Synergistic Cytotoxic Effector Molecules washing. Target cells  were then incubated with effectors  under the 
standard conditions in microtiter plates for four hours. Triplicate 
wells were combined at harvest, pelleted cells were labeled with 
8/,g/ml of the DNA stain HOECHST 33342 (Sigma Chemical 
Co., St. Louis, MO) for 15 min, propidium iodide was added (10 
/~g/ml  final  concentration), and the cells  were examined  in a fluores- 
cence microscope with a HOECHST falter set. Target cells were 
identified  by their red membrane  stain, and their nuclear  morphology 
was assessed as normal or apoptotic. 
Results 
Characterization of mRNA  and Protein Expression in RBL- 
cy-gzb  Transfectant Clones.  Following  a  generally  similar 
strategy to that previously used with granzyme A, RBL cells 
were transfected by use of expression vectors with granzyme 
B cDNA, or with both granzyme B and cytolysin cDNAs, 
and individual transfectant clones were isolated and charac- 
terized. Fig.  1 A  shows Northern blots measuring expres- 
sion of the CTL granule mRNAs cytolysin, granzyme A, 
granzyme B, as well as the housekeeping gene 3-actin. All 
seven R.BL-cy-gzb transfectant clones express cytolysin and 
granzyme B mP,  NA, but no granzyme A mRNA, as seen 
by a comparison with  the cloned CTL control.  Fig.  1 B 
presents  quantitative data derived from these blots, as well 
as the expression of granzyme B enzymatic activity (hydrol- 
ysis of its enzymatic substrate Boc-Ala-Ala-Asp-pNA (BAAD- 
pNA) measured on extracts of these clones. The parental RBL 
line expresses a negligible level of cytolysin or either gran- 
zyme. Five of the seven RBL-cy-gzb clones studied in detail 
express higher levels of cytolysin mP-.NA than the reference 
cloned CTL line used for comparison, while the total range 
of expression  levels of this mRNA was approximately 10- 
fold. In contrast, however,  granzyme B mRNA as well as 
enzymatic activity in all seven clones was lower than that 
of the CTL clone.  Expression levels of cytolysin and gran- 
zyme B mRNAs were not correlated in these RBLcy-gzb 
transfectant clones, although as expected, granzyme B mRNA 
levels correlated well with its enzymatic expression. The clones 
with the highest granzyme B expression had 40-50% of the 
levels expressed  in the reference  CTL clone. 
Cytotoxic Activity of RBL-cy-gzb Transfectant Clones.  The 
cytotoxic activity of RBL-cy-gzb, RBL-cy, and RBI~gzb clones 
was assessed on both red cell and tumor targets by use of 
standard 4-h assays. Fig.  2 shows cytotoxicity results with 
several of the most active clones of each type tested on two 
tumor targets. In agreement with our previous results (15), 
RBL-cy showed significant but weak cytolytic activity against 
such targets, as seen by S'Cr release, and negligible nucleo- 
lytic activity, as measured by 125I-DNA release.  Generally 
similar results were obtained with EL4 thymoma and P815 
mastocytoma targets. As shown by the horizontal distance 
between titration curves in Fig.  2, the most active RBL-cy- 
gzb clones were 3-4-fold more active than the most active 
RBL-cy clones in mediating the lysis (51Cr release) of EL4 
and P815 targets, and were <10-fold more active  in their 
ability to cause  125I-DNA release. These cytolytic activities 
were roughly 30-70-fold less than cloned CTL, while the 
nucleolytic activity was >100-fold less than CTL. In all cases, 
cytotoxic activity was negligible in the absence of IgE otTNP 
antibody (data not shown), as previously shown for RBLcy 
and RBL-cy-gza (14). In contrast to the RBL transfected with 
cytolysin, RBL-gzb clones were in no case active against tumor 
targets. 
When red cell targets were tested, a potent hemolytic ac- 
tivity was obtained as a result of cytolysin expression  as de- 
Figure  1.  Expression  of cytolysin  and granzyme  B in RBL transfectant  clones. (A) A Northern blot hybridized  with probes for cytolysin,  granzyme 
A, granzyme  B, and 3-actin of RNA of seven RBl.-cy-gzb  clones and the CTL and RBL controls. (B) The quantitative  expression  of these mRNAs 
normalized to actin and expressed as a percentage, relative to the CTL control. In addition, the expression of granzyme B protein was assessed by 
assaying  a detergent  lysate  of each  cell  type  for hydrolysis  of the granzyme  B substrate  BAAD-pNA. This  activity  is also  plotted  relative  to the CTL control. 
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Figure 2.  Cytotoxic  activity of 
the  most  active of each type  of 
RBL transfectant on tumor targets. 
Several clones of each type were 
included,  and the mean data  for 
several experiments with each trans- 
fectant type were averaged and are 
shown with the SEM. The follow- 
ing were included: RBL (three ex- 
periments); RBbgza (two clones, 
two  experiments  each); RBL-gzb 
(two clones, two experiments each); 
RBL-cy (three clones, three experi- 
ments  each); RBbcy-gza  (three 
clones, four experiments  each); RBb 
cy-gzb (clones 501, 528, and 809, 
four experiments  each); RBI,q,-gza- 
gzb (clones 5011, 5014, 5015, and 
50110,  three  experiments  each). 
The cytotoxic activity of a single 
cloned CTL line, redirected by use 
of aCD3xaTNP heteroconjugate, is 
shown  for  comparison.  The  top 
panels show the results with EL4 
lymphoma targets, and the bottom 
panels show the results with P815 
mastocytoma targets. The left panels 
show the release of SlCr, while the 
right  panels show  the  release of 
lzSI-DNA after detergent treatment. 
The assay  incubation  time was 4 h. 
scribed previously (14), but there was no enhancement of this 
hemolytic activity attributable to granzyrne B expression (Fig. 
3).  This result  is similar  to that  obtained previously with 
granzyme A  (15).  Fig.  3 displays  the results with the same 
clones as were shown in Fig. 2, and the contrast with tumor 
targets  is clear. 
Although  the results shown in Fig. 2 represent the most 
cytotoxic of the clones studied, there was considerable varia- 
tion within each group. To assess whether the expression levels 
of one or the other of these genes might limit the cytotoxic 
activity of the RBL-cy-gzb transfectants,  the cytotoxic ac- 
tivities of each of these clones on tumor targets were plotted 
against  their level of expression of cytolysin and granzyme 
B (Fig.  4).  It can be seen  that  while neither  cytolytic nor 
nucleolytic activities were significantly correlated with cyto- 
lysin mRNA expression (A), both activities on both targets 
are significantly correlated with the level of granzyme B en- 
zymatic activity (p <0.0025  for all "four independent  vari- 
ables, B). As expected from Figs.  4 and 1 B, a similar plot 
against granzyme B mRNA expression also shows a significant 
correlation  (p <0.0025  for the activities on EL4, p  <0.025 
for the activities on P815; data not shown). When cytolytic 
activity against RBC targets was similarly tested for correla- 
tion with expression levels, this activity showed no significant 
correlation  with  either  granzyme  B level,  but did show a 
significant positive correlation with cytolysin mRNA levels 
(p <0.01;  data not  shown). 
mRNA  and Protein Expression in RBLcy-gza-gzb  Transfec- 
tant  Clones.  To examine the cytotoxic properties  of RBL 
transfectants  expressing both granzyme A and B as well as 
cytolysin, a most potent RBL-cy-gzb clone (#501) was secon- 
darily transfected with granzyme A cDNA as previously de- 
scribed (14), this time by use of the blasticidin selection marker. 
Again,  individual clones were isolated and their expression 
levels and cytotoxic activities studied.  Fig. 5 A shows Northern 
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Figure 3.  Cytotoxic  activity of the most active of each type of RBL 
transfectant on red cell targets. The same clones as were shown in Fig. 
2 are shown in experiments with human red cells as targets. Again, CTL 
were redirected by use of aCD3xaTNP heteroconjugate. 
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and granzyme B enzymatic activity in lysates (B) for EL-4 targets  (left) 
and P815 targets (right).  In each case, the mean values of experiments  are 
shown.  Circles indicate  SlCr release and squares 12SI-DNA release. The 
clones (in increasing order of cytolysin expression) are 801, 806,528, 501, 
809, 802, and 808. 
blots of the expression of the three granule protein genes as 
well as 3-actin for 11 of these clones, and Fig.  5 B shows 
the quantitation of these mRNA levels. Not  surprisingly, 
there is less variability between the levels of cytolysin and 
granzyme B in these clones. The granzyme B mRNA ex- 
pression levels of these clones were 25-46% of the CTL level, 
as opposed to 40%  of the parental RBL-cy-gzb clone, and 
the cytolysin expression levels were 77-229%  of the CTL 
level. Expression levels of the newly acquired granzyme A 
mRNA ranged from 59 to 614% of the CTL level, and its 
enzyme activity ranged from 22 to 91%  of the CTL level. 
In this case, for unknown reasons, the enzymatic and mRNA 
levels did not correlate well with each other. 
Cytotoxic Activity of RBL-cy-gza-gzb Clones.  As shown in 
Fig. 2, the most active of the 11 RBL-cy-gza-gzb clones studied 
gave potent cytolytic and nucleolytic activities on both tumor 
targets examined. These activities were roughly 3 and 5 times 
less, respectively, than the cloned CTL line used as a com- 
parison, while they were 8-100 times more potent than the 
most potent of the RBL-cy-gza and RBL-cy-gzb clones. Fig. 
6 shows the cytotoxic activity of several of the most active 
RBL transfectant clones of each type plotted in terms of lyric 
units, which is a linear measurement of relative cytotoxic ac- 
tivity. These data show clearly that both the cytolytic (A) 
and nucleolytic (B) activity of the triple transfectants is con- 
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siderably greater than the sum of the two types of double 
transfectant, implying a synergistic interaction between the 
two granzymes in their ability to cause cytolysis and DNA 
damage. The granzyme expressions for the transfectant clones 
used in this comparison are shown in Fig.  6, which argues 
that the enhanced cytotoxic activity of the triple transfec- 
tants is not due to higher expression of granzymes than the 
double transfectants used for comparison. 
As was the case with RBL-cy-gzb clones, there was con- 
siderable variation in cytotoxic activity among the individual 
RBbcy-gza-gzb clones. Fig. 7 shows the cytolytic and nucleo- 
lytic activity of each of the 11 clones on four different tumor 
lines plotted as a function of their granzyme A  enzymatic 
activity.  The  cytolytic activity  is  significantly correlated 
(p <0.001) with granzyme A activity in three of four of these 
target cells (with Jurkat the exception), while the nucleo- 
lyric activity  is  significantly correlated ~  <0.0005)  with 
expression of this protease in all four cases. Activity correla- 
tions with granzyme A  mRNA levels were generally sig- 
nificant, but the fits were much better with the enzymatic 
activity data.  Because  these triple transfectant clones were 
derived from a single RBL-cy-gzb clone, they did not show 
a large range of expression of cytolysin and granzyrne B (Fig. 
5).  Although their cytotoxic activities also correlated with 
granzyme B expression, this was less significant because of 
the smaller range. No correlation with cytolysin expression 
was found (data not shown). 
In contrast to the results with tumor target cells, the most 
active RBL-cy-gza-gzb clones showed no greater activity on 
RBC targets than did the other cytolysin expressing KBL 
transfectants (Fig. 3). In analyzing the activity of individual 
clones on RBC targets,  a highly significant (p <0.0005) posi- 
tive correlation was found with cytolysin mRNA expression. 
However, the roughly threefold range of cytolysin mRNA 
expression of these clones gave only a small variation in lyric 
activity. Granzyme expression levels of these triple transfec- 
tant clones showed no significant correlation with cytotoxic 
activity on RBC  targets. 
Induction of Apoptotic Morphology in Target Nuclei by RBL 
Transfectants.  While the release of lzSI-DNA into the super- 
natant was clearly enhanced by granzymes A and B, this is 
only one criterion of apoptotic death. To confirm that gran- 
zyme expression was associated with apoptotic target death 
characteristics, target cells were marked for identification in 
the fluorescence microscope by use of a fluorescent lipid analog, 
thus allowing target nuclei to be examined microscopically 
for chromatin condensation and nuclear fragmentation after 
incubation with RBL transfectants.  Fig. 8 shows that for two 
tumor targets, IgE-dependent apoptotic nuclear damage was 
seen with the triple transfectants but not with RBL-cy. After 
4 h, target nuclei showed both chromatin condensation and 
nuclear fragmentation in  those cases  in  which  significant 
125I-DNA release had been detected. 
Discussion 
The studies described here make a strong case for the im- 
portance of granzymes in mediating target cell death by cyto- Figure  5.  Expression of cytolysin, granzyme A, and granzyme B in individual RBl:cy-gza-gzb clones. As in Fig. 1, A shows Northern blot analysis 
of R.NA preparations  made for each RBL transfectant  clone with the four probes indicated. B shows the quantitation  of these mRNA expression 
levels, expressed as a percentage relative to the reference CTL clone. 
toxic lymphocytes. They demonstrate the strengths of the 
approach we have used, that is, the controlled expression of 
lymphocyte granule components in noncytotoxic cells pos- 
sessing  a  regulated secretory pathway.  The  most  striking 
findings were that, while cytolysin is required for the cyto- 
toxic activity of RBL,  granzyme expression is the limiting 
factor in the cytotoxic activity of the RBL transfectants we 
have prepared. Furthermore, the cooperative interaction be- 
tween granzymes A  and B in mediating this activity sug- 
gests that  these granzymes have evolved to  maximize this 
synergistic effect, since these two (or close analogs) seem to 
be expressed  in all cytotoxic lymphocytes studied. 
It is clear that granzyme B by itself has the ability to en- 
hance  the  cytolytic and  especially  nucleolytic activity  of 
cytolysin-expressing RBL cells. The most active of our RBL- 
cy-gzb clones were not significantly different in this respect 
from the most active of our RBL-cy-gza clones, and we spec- 
ulate that these proteases are roughly equal in their ability 
to cause lethal target cell damage. However, we have not at- 
tempted to compare this activity of granzymes A and B on 
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Figure 7.  Cytotoxic  activity of 
individual RBbcy-gza-gzb clones as 
a function of granzyme A expres- 
sion.  Mean  marker  release values 
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shown with the following fixed E/T 
ratios: (upper left) EL4 targets, E/T 
=  10; (upper right)  P815 targets, 
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gets, E/T  =  10; (lower rigfit) L929 
targets,  E/T  =  30. 
a molecular basis because of the difficulty in estimating how 
many protease molecules are being delivered to the target cell. 
Nevertheless, our results do not support the speculation that 
granzyme B might be particularly efficient in mediating target 
death because its preference for Asp at its cleavage site is nomi- 
nally similar to that of IL-l-converting enzyme, which shows 
homology to the Caenorhabditus elegans death gene ced-3 (23, 
24).  The finding that granzyme B contributes to target cell 
lethal damage is in agreement with a recent study of gran- 
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Figure 8.  Apoptotic target cell nuclear morphology during cytoxicity 
is associated with granzyme expression in RBL transfectants. EL4 and 
P815 targets were prelabeled with the lipid probe Di-IC16 to allow their 
recognition in the fluorescent microscope, and the standard 4-h cytotox- 
icity incubation  was carried out with and without IgE anti-DNP. Nuclear 
DNA staining with HOECHST 33342 was carried out, and target nuclei 
were scored as apoptotic (condensed chromatin and/or nuclear fragmenta- 
tion) or normal. 
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zyme B knockout mice (12), in which primary CTL from 
such mice killed tumor target cells with slower kinetics than 
CTL from control mice, with DNA damage being affected 
more than target lysis. 
By quantitating both the cytotoxic activity of individual 
clones as well as the expression levels of these granule genes, 
we were able to look for quantitative correlations and thus 
implicate the transfected molecules whose expression con- 
tributes to the cytotoxic activity. It is clear that cytolysin ex- 
pression is necessary for cytolytic activity since RBL cells ex- 
pressing these proteases alone were not cytotoxic (Fig. 2 and 
reference 15).  These results are expected given the general 
lack of cytotoxic activity of proteases on intact cells. How- 
ever, within the range of cytolysin mRNA expression in our 
various RBL-cy transfectants, we observed no overall correla- 
tion  of cytolytic activity on  tumor  targets  and  cytolysin 
mRNA levels, although at the lowest expression levels there 
may be an effect (Fig. 4 A). In contrast, with RBC targets, 
the level of cytotoxicity was clearly correlated with cytolysin 
mRNA levels, although the potent RBC killing activity in- 
creased only modestly over the 10-fold range of cytolysin ex- 
pression of the clones (data not shown). These results bring 
out the strong differences between red cell and tumor targets 
and strongly suggest that the modest cytotoxic activity of 
RBL-cy on tumor targets is unlikely to be due to inadequate 
delivery of cytolysin protein to the target membrane. 
In contrast to cytolysin, the expression levels of granzymes 
significantly correlated with cytotoxic activities on tumor cell 
targets. By analysis of RBL-cy-gzb clones, granzyme B ex- 
pression levels were shown to correlate with both cytolytic (SlCr release) and nudeolytic (12SI-DNA release) activities on 
two tumor targets (Fig. 4 B), while for the RBL-cy-gza-gzb 
clones derived from one of these, the expression levels of gran- 
zyme A correlated with cytotoxic activities on three of four 
targets and with nucleolytic activity on all four targets (Fig. 
7). These results show that the cytotoxic activities of these 
RBL transfectants are limited by expression of both gran- 
zymes, although we were unable to obtain granzyme B ex- 
pression levels comparable to those of our reference  CTL clone. 
These results on both tumor and red cell targets are com- 
patible with the granule exocytosis model for cytotoxicity 
if it is assumed that,  with tumor target cells,  the role of 
cytolysin is largely to permeabilize the target membrane to 
allow access of granzymes to the target cell cytoplasm. Al- 
though  the original concept behind this  model was  that 
cytolysin-induced membrane damage was lethal to the target 
cell, our results show that this seems to be true only for red 
cells. The difference between red cell and tumor targets can 
best be explained by the ability of the latter to repair mem- 
brane damage due to inserted pores, as has been dearly demon- 
strated by studies with complement, in which >10-fold more 
membrane attack complexes are required to kill nucleated cells 
than red cells (25). This corresponds to our experience with 
cytolysin, in which we found that 50-200 times more cytolysin 
was required to kill nudeated cells than red cells (2). The 
RBbcy transfectants deliver enough cytolysin via degranula- 
tion to kill red cell targets very efficiently, but tumor cells 
are quite resistant to these effectors. Previous results showed 
that roughly equal RBL cell degranulation was triggered by 
IgE bound to red cell and tumor cell surfaces (13), implying 
that some property of the target per se is responsible for the 
difference in cytolytic susceptibility. Membrane damage re- 
pair best explains the present finding that nucleated cell killing 
did not correlate with cytolysin expression in the RBbcy- 
gzb clones, even though these clones had a ~10-fold range 
of cytolysin expression. This could imply that the tumor cell's 
repair capacity can efficiently handle multiple pores inserted 
close to each other on a patch of membrane opposite the de- 
granulation event. In contrast, red cells, having no membrane 
repair capacity, are sensitive  to far less cytolysin secreted by 
RBL effectors. 
These results are compatible with a series of experiments 
in which granzymes have been shown to mediate nuclear 
damage in permeabilized target cells. We described the ability 
of granzyme A purified from CTL granules to mediate 12sI- 
DNA release from detergent- or cytolysin-permeabilized cells 
(6), and Shiet al. (11) described a series of several granzymes 
from rat NK granules that had a similar ability using cyto- 
lysin-permeabilized cells. The active NK granzymes, termed 
fragmentins, included a granzyme B-like protease with an 
"Asp-ase"  enzymatic specificity,  and two granzymes with 
"tryptase" activity similar to granzyme A. These results are 
compatible with the finding that both RBlccy-gza and RBL- 
cy-gzb cause target death with accompanying DNA damage. 
Although the molecular relationship between the nucleolytic 
and cytolytic target cell damage has not been explained, it 
appears that granzymes trigger a damage pathway in which 
they are linked. 
The expression of seven different granzymes in mouse CTL 
(8) has been puzzling since their description. If indeed their 
primary function is in triggering a cytotoxic pathway in target 
cells, then there are two explanations for granzyme hetero- 
geneity that are not mutually exclusive. One is that the het- 
erogeneity enhances the range of targets in which this efficient 
cytotoxic mechanism can operate, since the DNA damage 
in different target cell types appears to have different relative 
susceptibilities to different granzymes (11). The other expla- 
nation is that they interact cooperatively to trigger a death 
pathway(s) in target cells, as suggested again by experiments 
showing cooperation between granzyrne A- and B-like frag- 
mentins in mediating DNA damage (11). The apparent syn- 
ergism for both cytolysis and DNA damage in RBL expressing 
both granzymes A and B shown in Fig. 6 lends further sup- 
port to the possibility that these two enzymes cooperate in 
triggering a cell death response in target cells. This finding 
is interesting in light of the finding that granzymes A and 
B are the only granzymes expressed in granules from the lyti- 
cally potent CTL produced in vivo by allogeneic stimulation 
in the peritoneal cavity (8). 
The molecular death pathways triggered by granzymes in 
nucleated target cells need to be defined. Although the most 
obvious place to start is the identification of the physiologi- 
cally relevant molecular substrates cleaved by these granzymes, 
it is often difficult to establish whether a particular substrate 
cleaved is required for cell death. The nuclear matrix protein 
nucleolin has been identified as a granzyme A substrate (26), 
but the evidence implicating this in target cell death is cir- 
cumstantial.  An interesting effect of the granzyme B-like frag- 
mentin from NK granules is its ability to trigger activation 
of the protein kinase cdc2, which controls the entry of cells 
into mitosis (27).  Thus, it has been proposed that the nu- 
clear changes characteristic of mitosis could be triggered in- 
appropriately, resulting in a "mitotic catastrophe." Although 
the precise proteolytic cleavages have not been defined in this 
system, it is an appealing explanation for the nuclear damage 
triggered by granzymes. However, while it is often assumed 
that there is a direct relationship between this apoptotic nu- 
clear damage and cell death, there are examples in which target 
lysis by CTL can be dissociated from nuclear damage (28-30). 
Jacobson et al.  (31) have recently shown that some stimuli 
causing apoptotic death also kill enudeated cytoplasts. We 
are currently using this approach to test whether nuclear events 
are necessary for the granzyme-mediated cytotoxic effect. 
We believe that the studies described here lend substantial 
support  to  the granule exocytosis model for lymphocyte- 
mediated cytotoxicity and further extend our understanding 
of the basic process of cytotoxic effector  function. By expressing 
the proposed granule mediators in a noncytotoxic effector 
cell with the appropriate secretory apparatus,  we have largely 
reconstituted the cytotoxic activities of potent cytotoxic lym- 
phocytes and provided strong evidence that the granzymes 
contribute in an important way to  target cell damage. 
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